High blood pressure has long been medicine's quiet adversary — present in over a billion lives, yet often invisible until the damage is done. On World Hypertension Day, Recor Medical draws attention to the stubborn third of patients for whom pills and lifestyle changes are not enough, offering a device-based therapy that quiets the overactive nerves driving their condition. The Paradise ultrasound renal denervation system, FDA-approved since late 2023, represents not a replacement for existing care but an expansion of what medicine can offer those left behind by it. Whether it will endure as a
PR Newswire UK
· May 15, 2026
· health
· 3 min de leitura
High
Apuração: Caracterizado
Recor Medical Promotes Ultrasound Therapy for Treatment-Resistant Hypertension
Hypertension affects over 1 billion people globally and remains a leading cause of heart attack, stroke, and kidney disease when uncontrolled.
◉
Health & Medicine
8098 artigos relacionados
Moderna's personalized mRNA melanoma vaccine shows promise in preventi…
CBS News · 100% correspondência
Blood test could predict Covid-19 mortality risk, study finds
BreakingNews.ie · 99% correspondência
Hadassah performs world's first alpha radiation treatment for recurren…
jpost.com · 99% correspondência
Dr. Reddy's Wins Semaglutide Approval as Novo Nordisk Patent Challenge…
NDTV Profit · 99% correspondência
EU safety committee reviews reports of menstrual changes after mRNA CO…
CNBC · 99% correspondência
Cobertura Relacionada
The Guardian · Aug 20
Hundreds of thousands await GCSE results as gender gap narrows to 10-year low
Hundreds of thousands of UK students received GCSE results showing overall grade improvements in 2025, with the gender g…
The Straits Times · Aug 20 Ebola spreads beyond Congo epicentre, overwhelming treatment capacityEbola cases in DRC are accelerating outside the initial Ituri epicenter, with North Kivu and Haut-Uélé provinces experie…
Science Daily · Aug 20 1,000+ genetic switches explain why women face higher autoimmune disease riskResearchers identified over 1,000 genetic switches that function differently in male and female immune cells, explaining…
News-Medical · Aug 20 Brain's Local Wiring May Buffer Cognitive Decline in Older AdultsUSC researchers found that white matter integrity helps protect cognitive function in older adults by compensating for g…
Viés e Enquadramento
Não há dados de análise detalhada para esta lente. Tente executar as lentes novamente no painel de administração.
Impacto Geopolítico
🌎
Medical device company promotes ultrasound therapy for hypertension; no geopolitical implications detected.
Escalation Risk
low
Confidence
HIGH
Lente Econômica
📈
Recor Medical promotes ultrasound renal denervation for treatment-resistant hypertension affecting ~1.3B people globally, targeting the one-third of patients uncontrolled by medication, signaling growth in specialized medical device markets.
Market Signal
bullish
Confidence
MED
Medical devices and diagnostics
Pharmaceutical/healthcare services
Cardiovascular treatment
Healthcare technology
Hospital and clinical services
Patients with resistant hypertension gain access to innovative minimally-invasive treatment options, potentially reducing long-term healthcare costs from cardiovascular complications (heart attacks, strokes, kidney disease) and improving quality of life, though device costs may initially be high.
Regulatory bodies (FDA, EMA) may accelerate approval pathways for innovative hypertension therapies; healthcare systems may need to evaluate reimbursement policies for device-based treatments; public health initiatives may shift toward earlier detection and specialist referral protocols for treatment-resistant cases.